ABSTRACT
The deterioration of motor skills and fine hand movement impairment associated with Parkinson’s disease (PD) hinders the performance of daily oral hygiene procedures. This study examined the periodontal health of people with PD using clinical and microbiological periodontal parameters measured at two time points during their medical follow-up.
This prospective cohort study included participants with PD. Clinical oral health data, including oral hygiene and periodontal status, as well as microbiological samples were collected at baseline and after follow-up for at least 3 months.
Forty people with PD were recruited (35% female; median [Q1–Q3] age: 65.3 [57.9– 72.8] years) and 35 were followed up. The participants had good hygiene habits, and the proportion of participants with a “good” plaque index improved during follow-up (+21 points, p = 0.239). The proportion of patients with periodontal pockets > 6 mm decreased from 20% to 3% (p = 0.131). This improvement was associated with a reduction in the Treponema denticola bacterial load (p = 0.003).
The oral hygiene of people with PD improved during this study. Although these promising results require confirmation, they are an important step toward enhancing oral care support for PD patients.
ClinicalTrials.gov Identifier: NCT03827551, registered on January 31, 2019, (https://clinicaltrials.gov/study/NCT03827551)
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT03827551
Funding Statement
This work was supported by France Parkinson.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The research protocol was reviewed and approved by a French regional ethics committee, the Comite de Protection des Personnes (CPP) Sud-Est III, approval number: EudraCT 2018-A02773-52.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos